Plasma Cell Neoplasm — Trials

Plasma Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 1,091 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06121843	A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma	recruiting	Phase 1	187	Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyINDUSTRY	2	Jul 16, 2026	clinicaltrials
NCT02343042	Selinexor and Backbone Treatments of Multiple Myeloma Patients(STOMP)	recruiting	Phase 1 / Phase 2	300	Karyopharm Therapeutics IncINDUSTRY